| Net income (loss) | 1.96M |
| Stock-based compensation expense | 4.08M |
| Non-cash interest expense on convertible debt | |
| Depreciation and amortization | |
| Amortization of capitalized debt issuance costs | |
| Provision for bad debts | |
| Accounts receivable | |
| Deferred maintenance fees | |
| Inventory, prepaid expenses and other current assets | |
| Accounts payable | -222K |
| Accrued payroll and related taxes | 1.2M |
| Deferred revenue | -67K |
| Deferred rent | |
| Other accrued liabilities | |
| Net cash provided by (used in) operating activities | |
| Purchases of short-term investments | |
| Purchases of property and equipment | -250K |
| Net cash used in investing activities | |
| Proceeds from the issuance of common stock, net of issuance costs of $1,154,634 and $0, respectively | |
| Proceeds from exercise of warrants and stock options | |
| Proceeds from line of credit | |
| Proceeds from the issuance of convertible debt, net | |
| Net cash provided by financing activities | |
| NET INCREASE IN CASH AND CASH EQUIVALENTS | 6.26M |
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | 2.75M |
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | 9.01M |
| Cash paid for interest | 1K |
| Cash paid for income taxes | 17K |
| Conversion of debt to common stock | |
| Debt discount on convertible note due to warrants | |
| Beneficial conversion feature related to convertible debt issued | |